Men's Health Prescription Medications
Researching men's-health prescription medications
This guide is designed for people comparing specific men's-health medicines before deciding what product they are actually looking for and how to obtain it through a legitimate pharmacy channel. The focus is product identity: brand name, active ingredient, strength, dosage form, manufacturer or market sponsor, prescription status, regulatory status, price context and current availability questions.
Those distinctions matter because a familiar active ingredient does not automatically make every brand containing it FDA-approved in the United States. Sildenafil and tadalafil are active ingredients used in FDA-approved U.S. prescription medicines, while some brands sold in other countries are separate products with their own manufacturers, registrations and market status. Dapoxetine is different again: FDA states that dapoxetine is not an FDA-approved active ingredient, although Priligy is an authorized prescription medicine in a number of non-U.S. markets.
Sildenafil product research
Sildenafil is a PDE5 inhibitor used in FDA-approved U.S. prescription products for erectile dysfunction. U.S. labeling includes 25 mg, 50 mg and 100 mg tablet strengths. The important commercial distinction is between sildenafil as an active ingredient and a particular branded tablet.
- Aurogra 100 mg is a sildenafil 100 mg product associated with Aurochem in Indian and export-market records. FDA enforcement material specifically describes Aurogra 100 imported into the United States as an unapproved drug product.
- Fildena 100 mg is a sildenafil 100 mg product listed by Fortune Healthcare in India. The brand should not be treated as interchangeable with an FDA-approved U.S. sildenafil product merely because the active ingredient and strength are familiar.
When comparing sildenafil products, verify the exact brand on the package, the manufacturer, the labeled amount of sildenafil, the dosage form, the market for which the product was labeled and whether the product itself has a recognized regulatory approval in the country where it is being obtained.
Tadalafil product research
Tadalafil is also a PDE5 inhibitor. FDA-approved U.S. tadalafil products are prescription medicines, and 20 mg tablets are an established U.S. strength. As with sildenafil, the ingredient's U.S. approval does not automatically extend to every foreign-market brand containing tadalafil.
- Tadacip 20 mg is a tadalafil 20 mg film-coated tablet with an active Australian registration sponsored by Cipla Australia. Its regulatory history is therefore product- and market-specific rather than simply a synonym for Cialis or for every generic tadalafil tablet.
- Vidalista 20 mg is listed by Centurion Laboratories in India as a tadalafil 20 mg tablet. Users researching it should distinguish that Indian brand identity from FDA-approved tadalafil products sold under U.S. applications and labels.
Price comparisons for these brands require care. A foreign-market brand may not have a normal U.S. retail cash price, insurance price or pharmacy availability profile. A quoted online price is not proof that the exact product is approved, authentic or lawfully supplied in the buyer's jurisdiction.
Premature-ejaculation medication and dapoxetine
Priligy 30 mg contains dapoxetine and is authorized as a prescription medicine for premature ejaculation in several non-U.S. markets. Current French public medicine records list Priligy 30 mg as prescription-only and identify dapoxetine as its active substance. FDA, however, states that dapoxetine is not approved by FDA. For a U.S. reader, that difference is central to product research.
Brand, generic and manufacturer are different questions
A product name such as Aurogra, Tadacip, Fildena, Vidalista or Priligy is a brand identity. Sildenafil, tadalafil and dapoxetine are active ingredients. Manufacturer, marketing-authorization holder and distributor can be different entities, and those roles can change by country. A product may also be authorized in one national market while having no approval under the same brand in another.
For that reason, a useful comparison should start with the package and its market-specific regulatory record rather than with the assumption that products sharing an ingredient are the same commercial product.
Prescription, price and availability questions
Sildenafil and tadalafil used for erectile dysfunction are prescription medicines in the United States. Dapoxetine is not FDA-approved. Before trying to obtain any named brand, confirm whether the exact product is authorized in the relevant market, whether a prescription is required, whether a licensed pharmacy can lawfully dispense it, and whether the package and labeling match the product being discussed.
Prices can vary by country, pharmacy, quantity, insurance status and whether the product is a locally authorized brand or a foreign-market item. Davidson Pharmacy's current stock, price or dispensing status for any product on this page is not stated here and should not be inferred from the presence of an informational page.
Safety checks that matter when comparing products
Product research should include the active ingredient and major interaction warnings. U.S. sildenafil and tadalafil labeling contraindicates use with organic nitrates because of the risk of a clinically significant blood-pressure drop. Product authenticity, correct strength and a valid prescription are therefore part of the buying/access decision, not separate issues.
For dapoxetine products, the market-specific prescribing information should be checked for contraindications and interactions, including serotonergic medicines and conditions associated with fainting or cardiovascular risk. These are reasons to verify a product through a prescriber or pharmacist rather than relying only on the brand name or an online listing.
Research sources
The pages linked above separate product-specific facts from active-ingredient facts and use regulator or manufacturer records wherever available. For U.S. approval questions, FDA's Drugs@FDA, Orange Book and DailyMed records are the appropriate references; for foreign brands, the relevant national regulator or manufacturer record is used to establish product identity and market context.